<?xml version="1.0" encoding="UTF-8"?>
<p>Immunomodulation induced by MSC therapy in solid organ transplant recipients has only recently been explored 
 <xref rid="sct312264-bib-0014" ref-type="ref">14</xref>. Intravenous administration of autologous bone marrow‚Äêderived MSC (two separate infusions of 1 million cells per kg) has been given to kidney transplant recipients showing histologic evidence of acute rejection, without serious adverse events reported 
 <xref rid="sct312264-bib-0015" ref-type="ref">15</xref>.
</p>
